Delivering tamoxifen within solid lipid nanoparticles

Pharmaceutical Technology

Volumn 35, Issue 4, 2011, Pages 74-79

  Abbasalipourkabir, Roghayeh ^a   Salehzadeh, Aref ^a   Abdullah, Rasedee ^b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

SOLID LIPID NANOPARTICLE; TAMOXIFEN;

ARTICLE; CELL STRAIN MCF 7; CHEMICAL MODIFICATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HOMOGENIZATION; HUMAN; IC 50; MELTING POINT; TRANSMISSION ELECTRON MICROSCOPY;

EID: 80051915246     PISSN: 15432521     EISSN: 21507376     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. G. Fontana et al., Drug Deliv. 12 (6), 385-392 (2005).
2. V.C. Jordan, Br. J. Pharmacol. 110 (2), 507-517 (1993).
3. E. Memisoglu-Bilensoy et al., J. Control. Release 104 (3), 489-496 (2005).
4. J.S. Chawla and M.M. Amiji, Int. J. Pharm. 249 (1-2), 127-138 (2002).
5. K. Jores et al., Pharm. Res. 22 (11), 1887-1897 (2005).
6. H. Yuan et al., Colloids Surf. B. Biointerfaces 61 (2), 132-137 (2007).
7. K. Westesen, H. Bunjes, and M.H.J. Koch, J. Control. Release 48 (2-3,), 223-236 (1997).
8. A.Z. Mühlen, C. Schwarz, and W. Mehnert, Eur. J. Pharm. Biopharm. 45 (2), 149-155 (1998).
9. M.A. Schubert and C.C. Müller-Goymann, Eur. J. Pharm. Biopharm. 61 (1-2), 77-86 (2005).
10. R. Lander et al., Biotechnology Progress 16 (1), 80-85 (2000).
11. A.A. Attama and C.C. Müller-Goymann, Int. J. Pharm. 334 (1-2), 179-189 (2007).
12. I. Mountasser, H. Fessi, and A.W. Coleman, Eur. J. Pharm. Biopharm. 54 (3), 281-284 (2002).
13. I. Brigger et al., Int. J. Pharm. 214 (1-2), 37-42 (2001).
14. F. Ikom, G.K. Hanna, and G.W. Schmid-Schmid, Lymphology 32 (3), 90-102 (1999).
15. D.Z. Hou et al., Biomater. 24 (10), 1781-1785 (2003).
16. H.L. Reddy et al., Pharm. Dev. Tech. 11 (2), 167-177 (2006).
17. H.L. Wong et al., J. Pharm. Sci. 93 (8), 1993-2008 (2004).
18. H. Yuan et al., Int. J. Pharm. 348 (1-2), 137-145 (2008).
19. A. Maschke et al., Eur. J. Pharm. Biopharm. 65 (2), 175-187 (2007).
20. S.A. Wissing, O. Kayser, and R.H. Müller, Adv. Drug Deliv. Rev. 56 (9), 1257-1272 (2004).
21. L. Serpe et al., Anticancer Drug 15 (5), 525-536 (2004). PT